Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026
Offer reference number: CM/TNS/25/5725
Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
CM/TNS/25/5725/01 – Regional award for Denosumab Injection:
NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months)
SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months)
MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months)
LNW: (London) 01/01/2026 to 31/12/2026 (12 months)
CM/TNS/25/5725/02 – National award for Denosumab Injection:
7NAT (National) 01/01/2026 to 31/12/2026 (12 months)
Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England